Skip to main content
. 2020 Mar 31;141(17):1371–1383. doi: 10.1161/CIRCULATIONAHA.119.044366

Figure 4.

Figure 4.

Time from initial evaluation to developing incident hypertrophic cardiomyopathy with left ventricular systolic dysfunction (HCM-LVSD). Rates of developing incident HCM-LVSD were 1.7% (95% CI, 1.4–2.2) at 5 years, 4.5% (95% CI, 3.8–5.3) at 10 years, and 7.5% (95% CI, 6.5–8.6) at 15 years. SHaRe indicates Sarcomeric Human Cardiomyopathy Registry.